Thus, blocking CDK4/6 and cell cycle progression is protective in gradually progressive models of CKD (e.g., hypertension) but not after an acute ischemic event when rapid cell cycle progression is critical for repair. This evidence concerns the gene CDK4 and chronic kidney disease.